1. Microneedle patches incorporating zinc-doped mesoporous silica nanoparticles loaded with betamethasone dipropionate for psoriasis treatment
- Author
-
Jun Li, Zhiguo Yuan, Shuyu Shi, Xingtao Chen, Shuangshuang Yu, Xiaoshu Qi, Tong Deng, Yifei Zhou, Dan Tang, Saihong Xu, Jue Zhang, Yingfu Jiao, Weifeng Yu, Liya Wang, Liqun Yang, and Po Gao
- Subjects
Microneedle ,Mesoporous silica nanoparticle ,Psoriasis ,Itch ,Betamethasone dipropionate ,Biotechnology ,TP248.13-248.65 ,Medical technology ,R855-855.5 - Abstract
Abstract Treating psoriasis presents a major clinical challenge because of the limitations associated with traditional topical glucocorticoid therapy. This study introduced a drug delivery system utilizing zinc-doped mesoporous silica nanoparticle (Zn-MSN) and microneedle (MN), designed to enhance drug utilization for prolonged anti-inflammatory and anti-itch effects. The MN system facilitated the transdermal delivery of betamethasone dipropionate (BD), allowing its slow release. The BD@Zn-MSN-MN system promoted the polarization of macrophages towards the anti-inflammatory M2 phenotype, achieving superior anti-inflammatory effects compared to the clinically used BD cream. Additionally, this study demonstrated that BD@Zn-MSN-MN could further alleviate itching in psoriasis-afflicted mice by decreasing the excitability of the transient receptor potential vanilloid V1 (TRPV1) ion channel positive neurons and reducing the release of calcitonin gene-related peptide (CGRP) in the dorsal root ganglion (DRG). These findings offer new insights and effective therapeutic options for the future design of transdermal drug delivery for psoriasis.
- Published
- 2024
- Full Text
- View/download PDF